Whether B cells serve as antigen-presenting cells (APCs) for activation of pathogenic T cells in the multiple sclerosis model experimental autoimmune encephalomyelitis (EAE) is
Whether B cells serve as antigen-presenting cells (APCs) for activation of pathogenic T cells in the multiple sclerosis model experimental autoimmune encephalomyelitis (EAE) is unclear. To evaluate their role as APCs, we engineered mice selectively deficient in MHC II on B cells (B-MHC II
/ ), and to distinguish this function from antibody production, we created transgenic (Tg) mice that express the myelin oligodendrocyte glycoprotein (MOG)-specific B cell receptor (BCR; IgH MOG-mem ) but cannot secrete antibodies. B-MHC II / mice were resistant to EAE induced by recombinant human MOG (rhMOG), a T cell-and B celldependent autoantigen, and exhibited diminished Th1 and Th17 responses, suggesting a role for B cell APC function. In comparison, selective B cell IL-6 deficiency reduced EAE susceptibility and Th17 responses alone. Administration of MOG-specific antibodies only partially restored EAE susceptibility in B-MHC II / mice. In the absence of antibodies, IgH MOG-mem mice, but not mice expressing a BCR of irrelevant specificity, were fully susceptible to acute rhMOG-induced EAE, also demonstrating the importance of BCR specificity. Spontaneous opticospinal EAE and meningeal follicle-like structures were observed in IgH MOG-mem mice crossed with MOG-specific TCR Tg mice. Thus, B cells provide a critical cellular function in pathogenesis of central nervous system autoimmunity independent of their humoral involvement, findings which may be relevant to B cell-targeted therapies. (E) Lymphocytes were isolated from the spleen and CNS of the indicated mouse strains after disease onset and stimulated with PMA + ionomycin for 6 h, and IL-17 and IFN- production was assessed by flow cytometry. Flow cytometry plots from a representative mouse are shown (left), and graphs (right) show quantitative data from five to six mice/group. Results are representative of two independent experiments (n = 5 mice/group [C] ; n = 7-8 mice/group [D] ). For all EAE experiments, mean disease score ± SEM is shown. For all experiments: *, P < 0.05; **, P < 0.01 by Mann-Whitney U test.
glycoprotein (MOG) peptide 35-55 (p35-55) induces EAE in B cell-deficient mice and does not elicit strong humoral responses in WT mice (Fillatreau et al., 2002; Lyons et al., 2002) . In contrast, immunization of WT mice with recombinant human MOG (rhMOG) protein induces B cell activation and production of anti-MOG antibodies, which are pathogenic only in association with T cell-mediated CNS inflammation (Lyons et al., 2002; Oliver et al., 2003; Marta et al., 2005) . As B cell-deficient mice are resistant to EAE induced by immunization with rhMOG, this model is considered both T cell and B cell dependent. Therefore, this EAE model is well suited to evaluate the dual cellular and humoral roles of B cells in CNS autoimmunity. It is recognized that B cells are capable of processing native Ags and are very efficient APCs when they recognize the same Ag as the responding T cells (Constant et al., 1995a,b) . When MOG-specific BCR knockin (IgH MOG-ki ) mice (Litzenburger et al., 1998) , which are capable of secreting all Ig isotypes, were crossed to MOG-specific TCR (TCR MOG ) mice (Bettelli et al., 2003) , the progeny developed a spontaneous form of EAE that affected primarily the optic nerves and spinal cord (Bettelli et al., 2006a; Krishnamoorthy et al., 2006) . Spontaneous opticospinal EAE (OSE) was associated with development of MOG-specific Th17 responses and signs of B cell activation, findings suggesting a role for B cell APC function (Bettelli et al., 2006a; Krishnamoorthy et al., 2006) . Meningeal B cell aggregates containing germinal center-like structures resembling the ectopic B cell follicles identified in the leptomeninges in secondary progressive MS (SPMS) patients were also 1994). Further, it has been suggested that the meningeal B cell follicles detected in progressive MS may contribute to detrimental humoral immunity (Magliozzi et al., 2007) . Although it was the emphasis on humoral autoimmunity that provided the impetus to test B cell depletion in MS, the clinical benefit observed in recent clinical MS trials that tested anti-CD20 agents was not associated with reduction in serum or cerebrospinal fluid Ig titers, and oligoclonal antibodies were unchanged (Cross et al., 2006; Martin et al., 2009) . Besides serving as the source for antibody-secreting plasma cells, B cells express MHC class II (MHC II) molecules constitutively, and via up-regulation of co-stimulatory molecules, they can participate as APCs for activation of antigen (Ag)-specific T cells (Lanzavecchia, 1985; van der Veen et al., 1992; Constant et al., 1995b) . In this regard, reduction of proinflammatory Th17 cells has been observed in CD20-mediated B cell depletion in MS (Bar-Or et al., 2010) . Together, these observations suggest that, independent of their potential humoral participation, there is prominent cellular involvement of B cells in MS pathogenesis.
Distinguishing the separate cellular and humoral contributions of B cells in the pathogenesis of MS, and in its model experimental autoimmune encephalomyelitis (EAE), has been challenging. As myelin-specific T cells are essential for initiation of CNS inflammation and clinical manifestations, EAE is T cell dependent (Zamvil and Steinman, 1990) . B cells are not required in many EAE models, in particular those that are induced by encephalitogenic peptides of myelin proteins. In this regard, immunization with myelin oligodendrocyte Oliver et al., 2003) . Thus, only rhMOG-induced EAE is considered B cell dependent (Lyons et al., 1999; Oliver et al., 2003; Marta et al., 2005) . When serving as APCs, B cells can produce proinflammatory cytokines that promote development and activation of encephalitogenic T cells (Weber et al., 2010) . As IL-6 has a key role in Th17 differentiation (Okuda et al., 1999; Bettelli et al., 2006b ), we first addressed whether selective IL-6 production by B cells is required in rhMOG-induced EAE. No difference in disease course was observed between mice containing selective B cell IL-6 deficiency (CD19cre-IL-6 flox/flox ) and control (CD19cre-IL-6 wt/wt ) mice that were immunized with MOG p35-55 (Fig. 1 C) . In contrast, when immunized with rhMOG, mice containing IL-6-deficient B cells developed less severe EAE in comparison with control (CD19cre-IL-6 wt/wt and IL-6 flox/flox ) mice (Fig. 1 D) and exhibited reduced IL-17 production in both the periphery and the CNS (Fig. 1 E) . These results confirmed the importance of B cell IL-6 production in a model of B cell-dependent CNS autoimmunity.
B cell MHC II expression is required for rhMOG-induced EAE
Although cytokine production by accessory cells can promote proinflammatory T cell polarization, expression of MHC II on APCs is considered an obligate requirement for presentation and activation of Ag-specific CD4 + T cells (Schwartz, 1985 (Fig. 2 A) . The frequencies of B cells and CD4 + and CD8 + T cells were equivalent in BM chimeras containing either MHC II / or MHC II +/+ B cells (Fig. 2 A) . As shown in Fig. 2 (Fig. 2 C) , presumably because MHC observed in mice with spontaneous OSE (Bettelli et al., 2006a) . Furthermore, IgG1 was elevated in IgH MOG-ki × TCR MOG mice (Bettelli et al., 2006a; Krishnamoorthy et al., 2006) . Thus, similar to studies of MOG protein-induced EAE, the role of B cell APC function was not clearly distinguished from humoral immunity in OSE.
The goal of this investigation was to distinguish the role of APC function by B cells from the production and participation of myelin-specific antibodies in EAE pathogenesis. To this end, we used novel murine models that permitted us to evaluate requirements for B cell MHC II expression, BCR specificity and myelin-specific antibodies. First, we created mice that were selectively MHC II deficient on B cells (B-MHC II / mice). These B-MHC II / mice were susceptible to MOG p35-55-induced EAE. However, in comparison with mice containing B cells that expressed MHC II (B-MHC II +/+ ), which were susceptible to EAE induced by rhMOG, B-MHC II / mice were completely resistant to clinical or histological EAE, and they exhibited reduced Th1 and Th17 responses. Thus, B cell MHC II expression was required for EAE induction, which provided support for B cell APC function. Furthermore, administration of pathogenic MOG-specific antibodies only partially restored EAE susceptibility. To study B cell APC function in the absence of any possible contribution of antibodies, we created transgenic (Tg) mice containing B cells that expressed cell surface MOG-specific BCR but could not secrete antibodies. These MOG-specific "membrane-only" Tg (IgH MOG-mem )/B celldeficient (J H T; IgH MOG-mem /J H T) mice were fully susceptible to acute EAE induced by rhMOG, although their chronic course was slightly milder than that in either WT or IgH MOG-ki mice. Spontaneous OSE was observed in the absence of MOGspecific antibodies when IgH MOG-mem /J H T mice were crossed to MOG-specific TCR (TCR MOG )/B cell-deficient (J H T; TCR MOG /J H T) mice. In comparison with OSE in IgH MOG-ki × TCR MOG mice, the onset of OSE was delayed and severity was less in IgH MOG-mem /J H T × TCR MOG /J H T mice. Our results demonstrate that in models that require participation of B cells, their cellular function is necessary and sufficient for induction of CNS autoimmunity.
RESULTS

B cell IL-6 production promotes proinflammatory T cell polarization in rhMOG-induced EAE
Immunization with rhMOG induces EAE in C57BL/6J WT mice ( Fig. 1 A and Table 1 ), but not in B cell-deficient (J H T) mice ( Fig. 1 B and Table 1 ) or in B cell-depleted mice (not depicted). In contrast, MOG p35-55 and recombinant mouse MOG (rmMOG) can induce EAE in either WT mice ( Fig. 1 A) or B cell-deficient mice (Fig. 1 B ; Hjelmström et al., 1998; (cpm; left) . Data are presented as means of triplicate values ± SD and are representative of at least three independent experiments. Single-cell suspensions from spleens and CNS of the indicated mice were stimulated with PMA + ionomycin for 6 h, and frequencies of IL-17 + CD4 + Th17 and IFN- + CD4 + Th1 cells were assessed by flow cytometry. Representative FACS plots and quantification (mean ± SD) of n = 5 mice/group are shown (middle and right). For all experiments: **, P < 0.01; ***, P < 0.001 by Mann-Whitney U test.
MOG-reactive antibodies partially restore EAE susceptibility to rhMOG in B-MHC II / mice Antibodies specific for rhMOG are known to be pathogenic (Marta et al., 2005) . Although MHC II expression is required for B cell APC function, data indicate that MHC II is also necessary for germinal center formation and subsequent formation of long-lived plasma cells in T cell-dependent responses (Shimoda et al., 2006) . Thus, we analyzed production of MOG-specific antibodies in our B-MHC II / mice. Consistent with previous findings, MOG-specific antibodies were produced in control (B-MHC II +/+ ) mice in response to rhMOG and rmMOG, but not to MOG p35-55 (Weber et al., 2010) . In contrast, anti-MOG IgG was not detected in BM chimera mice containing MHC II-deficient B cells (Fig. 3 A) . Interestingly, these data are consistent with the initial work that demonstrated the importance of MHC II in II-competent myeloid cells also can process and present Ags. The contribution of MHC II expression by B cells in the development of pathogenic cells in vivo was also evaluated. No significant differences were observed in peripheral Th1 or Th17 responses in MOG p35-55-immunized BM chimera mice containing either MHC II +/+ or MHC II / B cells. Also, there were no differences in the frequency of CNS-infiltrating T cells or the number of CNS infiltrates in these mice (Fig. 2 C and Table 1 ). In contrast, in response to immunization with rhMOG, the frequency of splenic CD4 + T cells expressing IFN- and IL-17A was significantly decreased in B-MHC II / chimera mice. Furthermore, CNS inflammation was not detected in mice completely lacking MHC II only on B cells. Therefore, MHC II expression on B cells is critical for pathogenic T cell responses in rhMOGinduced EAE. Ar ticle 2927 organ-specific autoimmune diseases (Chan et al., 1999; Wong et al., 2004) . Thus, we created Tg mice containing B cells that express membrane MOG-specific Ig (IgH MOG-mem ) but are incapable of secreting Ig. We subcloned the rearranged heavy chain Ig gene from 8-18C5, the same gene used to create the IgH MOG-ki mice, which are capable of secreting all Ig isotypes, into a construct containing the IgM a constant region from which the exon encoding for secretion was excised (Fig. 4 A; see Materials and methods; Chan et al., 1999) . Mice bearing the IgH MOG-mem Tg were backcrossed onto the B cell-deficient J H T strain (IgH MOG-mem /J H T; Chen et al., 1993) to prevent the development of B cells expressing endogenous Ig. More than 50% of Tg B cells in the founder line #3088, which was chosen for most of our subsequent experiments, bound MOG protein similarly to B cells in other founder lines and in IgH MOG-ki mice (Fig. 4 B and not depicted) . B cells in those Tg mice also expressed MHC II comparably with IgH MOG-ki and WT mice (Fig. 4 C) . B cells in IgH MOG-mem / J H T Tg mice expressed cell surface IgM only (not depicted). Comparable frequencies of CD4 + , CD8 + , naive, and effector/ memory T cells were detected in IgH MOG-mem /J H T, WT, and IgH MOG-ki mice (not depicted).
The absence of secreted antibody in IgH MOG-mem /J H T mice was confirmed in separate analyses of total and MOGspecific IgM, as well as total and MOG-specific IgG in naive, MOG p35-55-immunized, and MOG protein-immunized mice (Fig. 4, D and E) . These antibodies were undetectable or observed only in trace amounts in IgH MOG-mem /J H T mice and were never significantly more than in B cell-deficient mice. In general, antibodies were 10 2 -10 3 times lower than WT controls. In contrast, naive and immunized IgH MOG-ki mice secreted much higher concentrations of MOG-specific IgM and IgG.
MOG-specific B cells, but not antibodies, are required for induction of B cell-dependent EAE IgH MOG-mem /J H T mice were tested for susceptibility to EAE by immunization with MOG p35-55, rmMOG, and rhMOG. Onset, severity, and disease course in IgH MOG-mem /J H T, WT, and IgH MOG-ki mice immunized with either MOG p35-55 or rmMOG were similar (Fig. 5 A and Table 3 ). Onset and initial clinical severity were also comparable when these mice were humoral immunity (McDevitt et al., 1972) . Absence of MHC II-expressing B cells was also associated with reduction of T follicular helper cells (Tfh cells; Deenick et al., 2010) , a specialized T cell subset which provides help for B cell maturation and isotype switching (Fig. 3 B ; Vinuesa et al., 2005; Deenick et al., 2010) . As B-MHC II / mice did not produce anti-MOG IgG, we tested whether antibodies could restore EAE susceptibility after immunization with rhMOG. Whereas transfer of isotype control OVA-specific mAb had no effect on EAE in B-MHC II / mice immunized with rhMOG ( Fig. 3 C and Table 2 ), administration of pathogenic anti-MOG mAb, 8-18C5, led to development of mild clinical disease, but did not restore EAE severity to the level observed in B-MHC II +/+ mice. Together, these results emphasize that the humoral contribution of B cells is insufficient to compensate for the lack of MHC II-dependent cellular function in MOG protein-induced EAE.
Besides serving as APCs or a source of autoantibodies, data indicate that through their cell surface-specific BCRs, B cells can transfer their target Ag to other professional APCs, a process which may be MHC II independent (Harvey et al., 2007) . Thus, we addressed whether MOG-specific B cells contribute to MOG protein-induced EAE independent of their expression of MHC II molecules. BM chimera mice containing only IgH MOG-ki B cells that expressed MHC II (IgH MOG-ki /MHC II +/+ ) were susceptible to EAE induced by MOG p35-55, rmMOG, or rhMOG (Fig. 3 D) . In contrast, BM chimera mice containing MHC II-deficient IgH MOG-ki B cells (IgH MOG-ki /MHC II / ) were susceptible to EAE induced by MOG p35-55 or rmMOG but not to EAE induced by rhMOG (Fig. 3 D) . Therefore, these results do not support BCR-mediated Ag exchange in rhMOG-induced EAE.
Generation of IgH MOG-mem Tg mice
In the experimental system we used thus far, disruption of cellular function (i.e., MHC II deficiency) of B cells was accompanied by a reduction in humoral autoimmunity. It was therefore important to generate a model that would permit examination of the role of MHC II-competent MOGspecific B cells without possible contribution of antibodies. Tg mice containing B cells that express membrane IgH only have been useful for studying APC function in systemic and (Chan et al., 1999) . V H 8.18 is the rearranged heavy chain V(D)J gene segment from the hybridoma 8-18C5 (Linnington et al., 1984) , which was used to generate IgH MOG-ki mice (Litzenburger et al., 1998) . 8.18-C5 is known to recognize rhMOG 1-125 (Menge et al., 2007 (Bettelli et al., 2006a) , and resembled similar structures observed in SPMS (Magliozzi et al., 2007) . Meningeal foci in IgH MOG-mem /J H T × TCR MOG /J H T mice were composed predominantly of B cells that infiltrate the parenchyma (Fig. 6 C) . Relatively fewer meningeal and parenchymal T cells were detected in these areas (Fig. 6 D) . Follicle-like organization was evident using a reticulin stain (Fig. 6 E) . Meningeal inflammation and follicle-like structures were not detected in clinically normal IgH MOG-mem /J H T × TCR MOG / J H T mice (Fig. 6 , F-J). Our observations indicate that the APC function of MOG-specific B cells is sufficient to cooperate with MOG-specific T cells in development of OSE and further suggest that in the context of CNS inflammation, anti-MOG antibodies augment phenotypic expression of this spontaneous disease.
DISCUSSION
Recent MS trials indicate that B cell-depleting agents have a profound beneficial effect, underscoring the importance of B cells in MS pathogenesis Hauser et al., 2008; Marriott and O'Connor, 2010; Kappos et al., 2011) .
Although it was the appreciation of the potential humoral contribution of B cells that inspired testing B cell depletion in MS, the clinical response was not associated with reduction in antibody levels Hauser et al., 2008; Marriott and O'Connor, 2010; Kappos et al., 2011) . B cells afford multiple functions. Besides serving as a source of antibodyproducing plasma cells, B cells can participate as APCs (Lanzavecchia, 1985; Constant et al., 1995a,b; Chan et al., 1999) in Ag transport (Phan et al., 2007) and as regulatory cells (Matsushita et al., 2008) . Although MHC II is expressed constitutively on B cells, it is unknown whether B cell Ag immunized with rhMOG. However, the IgH MOG-mem /J H T mice appeared to have a slightly milder disease course after the acute stage, although this difference was not statistically significant. A similar EAE course was observed in another IgH MOG-mem / J H T Tg founder line after immunization with rhMOG (not depicted). There were no obvious differences in the extent of meningeal or parenchymal CNS infiltration among any of these mice with EAE ( Fig. 5 B and Table 3 ). Data from our IgH MOG-mem /J H T mice demonstrated that it was the cellular and not the humoral contribution that was required for development of acute disease in B celldependent EAE. We therefore examined the role of BCR specificity by comparing EAE induction in our IgH MOG-mem / J H T mice with Tg mice containing B cells that express a fixed cell surface IgH specific for nitrophenyl, an irrelevant Ag. Membrane-only nitrophenyl-specific IgH (B1-8; IgH B1-8-mem / J H T) mice differ from IgH MOG-mem /J H T mice only in the specificity of their rearranged heavy chain gene (Chan et al., 1999) . In comparison with B cells from IgH MOG-mem /J H T, a much lower frequency of B cells from IgH B1-8-mem /J H T were capable of binding rhMOG (Fig. 5 C) . As anticipated, B cells from IgH B1-8-mem /J H T mice could present MOG p35-55 to MOG-specific 2D2 cells but were inefficient in presentation of MOG protein (Fig. 5 D) , which requires processing (Slavin et al., 2001; Bettelli et al., 2003) . Like IgH MOG-mem /J H T mice, IgH B1-8-mem /J H T mice were susceptible to EAE induced by MOG p35-55 or rmMOG, independent of BCR specificity. However, IgH B1-8-mem /J H T mice developed a much milder EAE course than IgH MOG-mem /J H T mice after immunization with rhMOG (Fig. 5 E) , which corresponded to a reduction in MOG-specific proinflammatory Th1 and Th17 cytokine responses in rhMOG-induced EAE (Fig. 5 F) . These results clearly support an important role for CNS auto-Ag BCR specificity in B cell APC function in vivo.
MOG-specific T and B cells cooperate in development of spontaneous OSE in the absence of MOG-specific antibodies
It was previously observed when TCR MOG mice were crossed with IgH MOG-ki mice, the progeny developed spontaneous paralysis, which was associated with meningeal and parenchymal inflammatory lesions within the optic nerves and spinal cord (OSE; Bettelli et al., 2006a; Krishnamoorthy et al., 2006) , a lesion topography reminiscent of neuromyelitis optica. OSE was also associated with elevation in MOG-specific IgG1, and as IgH MOG-ki B cells can also serve as APCs, it was not clear whether it was their potential role as APCs or production of MOG-specific autoantibodies that promoted development of OSE. Thus, to evaluate the participation of MOG-specific B cells, independent of MOG-specific antibodies, we crossed are representative of five independent experiments. (D) Sera from individual naive and immunized (MOG p35-55, rhMOG) WT, J H T, IgH MOG-ki , and IgH MOG-mem /J H T mice were obtained on day 14 after immunization, and serum Ig levels were calculated. Total and MOG-specific IgM and IgG titers are expressed as mean OD values ± SD from one of three representative experiments (performed in triplicate) from 1:2 serial dilutions. (E) Quantification of MOG-specific IgM and IgG (n = 6 mice/group) determined by ELISA are expressed as means of OD values or µg/ml ± SD of one of three representative experiments (performed in triplicate), respectively, and are shown on the logarithmic y axis. With greater appreciation for the role of B cells in MS, it is important to study MS models that require B cells for development of CNS autoimmunity. There are several different murine EAE models, and each one has merits that permit investigation of specific aspects involved in pathogenesis of CNS autoimmunity. With identification of encephalitogenic T cell epitopes within individual myelin Ags, most studies use those corresponding encephalitogenic peptides for EAE induction. In this regard, MOG p35-55 is frequently used in EAE studies. In general, B cells recognize conformational determinants created by longer contiguous or noncontiguous amino acid sequences within native proteins (Roelants, 1972) . Whereas MOG p35-55 activates encephalitogenic T cells (Kuchroo et al., 2002) , it does not efficiently activate B cells or promote MOG-specific antibody production (Weber et al., 2010) . In contrast, MOG protein efficiently leads to both B cell activation and production of anti-MOG antibodies (Weber et al., 2010) , and it is recognized that rhMOG, but not rodent MOG isoforms, induces EAE in a B cell-dependent manner (Marta et al., 2005) . Interestingly, this model is not DC dependent, as mice depleted of this myeloid APC subset were susceptible to EAE induced by MOG protein (Isaksson et al., 2012) . The B cell dependence of rhMOG-induced EAE is attributed to the presence of proline 42 (P42) in its sequence presentation may be required for activation of pathogenic CNS auto-Ag-specific T cells in vivo in EAE pathogenesis. In this investigation, we have created models that permitted us to evaluate and distinguish the role of B cells as APCs in vivo from their contribution to humoral CNS autoimmunity. Our results clearly demonstrate how B cell MHC II expression can be pivotal for activation of proinflammatory Th1 and Th17 cells in vivo and susceptibility to CNS autoimmunity. By generation of Tg mice that expressed cell surface myelin-specific BCR, we provided unequivocal evidence that B cell APC function, in the absence of humoral autoimmunity, is sufficient to drive proinflammatory T cell activation in vivo and EAE pathogenesis. Although BCR specificity for MOG protein promoted activation of encephalitogenic proinflammatory T cells, expression of this myelin-specific BCR was insufficient to drive proinflammatory T cell differentiation in the absence of B cell MHC II molecules (Fig. 3 D Onset indicates mean day of disease onset (paralytic EAE) ± SEM. Clinical score shows mean maximal score of paralytic EAE of diseased mice ± SEM. Composite data from three independent experiments with five to six mice per group are indicated. a The infiltration in the brain and spinal cord is quantified as averaged number of meningeal and parenchymal inflammatory foci (>10 clustered inflammatory cells) per CNS tissue section (five mice/group).
95% of B cells in CD19cre-MHC II flox/flox mice are MHC II deficient (Shimoda et al., 2006) . Although a minority of B cells expressed MHC II molecules, CD19cre-MHC II flox/flox mice were also resistant to EAE induced with rhMOG (unpublished data). Thus, with both approaches, the results were consistent in demonstrating the in vivo requirement for B cell MHC II expression for EAE induced by this myelin protein.
Although selective MHC II deficiency eliminated B cell APC function, it was also associated with a reduction in MOGspecific antibodies. One could contend that the absence of B cell MHC II expression simply eliminated the humoral response, which itself was primarily responsible for EAE pathogenesis. In our study, B cell MHC II deficiency resulted in a reduction in Tfh cells, a subset of CD4 + T cells that participate in germinal center formation, generation of memory B cells, and long-lived plasma cells (Crotty, 2011) . In this regard, B cell APC function is a prerequisite for humoral immunity as Ag presentation by responding B cells is required for development and maintenance of Tfh, especially when Ag is limiting (Deenick et al., 2010) . Nevertheless, it should be recognized that transfer of MOG-specific antibodies alone, or Tg-driven secretion of MOG-specific antibodies alone, does not lead to CNS inflammation and EAE (Linington et al., 1988; Genain et al., 1995; Litzenburger et al., 1998) , and, as we have observed, transfer of pathogenic anti-MOG antibodies into B-MHC II / mice that were immunized with rhMOG led to a partial restoration of EAE. Furthermore, despite MHC II expression on myeloid APCs, including DCs, there was a reduction in development of MOG-reactive Th17 cells in mice selectively deficient in B cell MHC II expression, implying direct B-T interaction in vivo. IgH "membrane-only" BCR Tg mice can distinguish B cell Ag presentation in vivo from humoral immunity (Chan et al., 1999) . Although not targeted to a defined self-Ag, IgH B1-8-mem Tg mice have served to distinguish the contribution of B cells in Ag presentation from their role in the generation of antibodies in murine lupus and arthritis (Chan et al., 1999; O'Neill et al., 2005) . To completely dissociate B lymphocyte cellular function from the potential contribution of humoral autoimmunity in EAE pathogenesis, we generated (Oliver et al., 2003; Marta et al., 2005) , as substitution of serine, the corresponding residue in rodent MOG, with P42 in rodent MOG protein confers B cell-dependent induction of EAE (Oliver et al., 2003; Marta et al., 2005) . Use of rhMOGinduced EAE also permitted us to evaluate the role of B cell cytokine production in expansion of proinflammatory T cells in vivo. Selective deficiency in MHC II-dependent B cell APC function was associated with significant reductions in both Th1 and Th17 cells. As it is recognized that B cells are a source of IL-6, a key Th17-polarizing cytokine (Bettelli et al., 2006b ), we investigated how B cell production of IL-6 itself influenced EAE susceptibility. Although selective B cell IL-6 deficiency did not significantly alter the course of MOG p35-55-induced EAE, onset of rhMOG-induced EAE was delayed, severity was attenuated and the frequency of Th17 cells only was significantly reduced in B cell IL-6-deficient mice. Similar results were obtained in mixed BM chimera mice containing IL-6-deficient B cells (unpublished data). These results underscore the importance of IL-6 production by activated B cells in Th17 differentiation in vivo in rhMOGinduced EAE. Interestingly, a recent study evaluated B cell IL-6 production in MOG p35-55-induced EAE and observed that B cell IL-6 production was not required for initiation of EAE, but that the disease course was reduced in mice containing IL-6-deficient B cells (Barr et al., 2012) . Thus, B cell IL-6 deficiency may have a variable effect when EAE is induced by MOG p35-55, but it is clear that the impact of B cell IL-6 production is greater in rhMOG-induced EAE. As rhMOG is currently the only known B cell-dependent encephalitogen, it may be advantageous to examine this myelin protein when evaluating the pathogenic role of activated myelin-specific B cells in EAE.
In this study, selective MHC II deficiency in B cells was evaluated using mixed BM chimera mice reconstituted with B cells from either WT mice or from MHC II-deficient mice, ensuring in the latter a complete absence of B cell MHC II expression and MHC II-restricted Ag presentation. As an alternative, we also examined selective B cell MHC II deficiency in CD19-targeted MHC II-deficient (CD19cre-MHC II flox/flox ) mice (Shimoda et al., 2006) . It is known that Indeed, greater severity could reflect contribution of pathogenic MOG-specific antibodies elicited by immunization of IgH MOG-ki or WT mice with rhMOG. However, given minor differences observed in the disease course, it may be experimentally challenging to dissect the contribution of anti-MOG antibodies in this model. With the recent introduction of new agents for relapsingremitting MS, the unmet need for successful therapy of progressive MS has become more evident (Fox et al., 2012; Brück et al., 2013) . Understanding of the genetic and pathogenic mechanisms involved in relapsing-remitting MS may also be advancing more rapidly (Sawcer et al., 2011) . Furthermore, it is recognized that there is a paucity of models for progressive MS (Amor et al., 1994; Bettelli et al., 2006a; Krishnamoorthy et al., 2006; Basso et al., 2008) . Although models do not entirely IgH MOG-mem /J H T Tg mice. B cells from our IgH MOG-mem / J H T mice efficiently presented MOG protein to MOG-specific 2D2 T cells and, despite the inability to secrete MOGspecific IgG or IgM, these mice were completely susceptible to acute clinical and histological EAE induced by rhMOG. Consistent with observations that B cells are more efficient APCs when they recognize the same target Ag as the responding T cells (Lanzavecchia, 1985; Constant et al., 1995a,b) , we observed that B cells from IgH MOG-mem /J H T mice presented rhMOG to 2D2 T cells and promoted proinflammatory Th1 and Th17 differentiation more efficiently than B cells from IgH B1-8-mem /J H T mice, which bound rhMOG less effectively. Furthermore, in contrast to IgH MOG-mem / J H T mice, IgH B1-8-mem /J H T mice were less susceptible to EAE induction by rhMOG. Collectively, these in vitro and in vivo findings demonstrate how myelin-specific B cells can have a critical role in presentation to myelin-specific T cells in CNS autoimmunity. Although onset of acute EAE was similar FcRIIB/FcRIIIA mAb (2.4G2; BD) to avoid nonspecific staining and were subsequently stained at 4°C using predetermined optimal concentrations of mAb for 30 min, as described previously (Weber et al., 2010) . Blood erythrocytes were lysed before staining using FACS lysing solution (BD). Antibodies to the mouse proteins CD45R (B220), FITC/PE/APC/PE-Cy7/PerCPCy5.5/APC-Cy7 (RA3-6B2), CD4 FITC/PE (RM4-4), CD4 APC/PECy7/PerCP-Cy5.5/APC-Cy7 (RM4-5), CD11c-APC (N418), CD11b-PE (ICRF44), CD44-PE (IM7), CD62L-APC (MEL-14), IgM-FITC (eB121-15F9), and IgD-FITC (11-26c) were purchased from eBioscience. MHC II I-Ab-FITC (AF6-120.1) was purchased from BD. Isotype-and concentration-matched control antibodies were used to assess nonspecific staining. In certain experiments, cells were fixed in 0.3% paraformaldehyde and kept at 4°C until analysis. Lymphocytes were examined by forward and side light scatter on a FACSCanto II flow cytometer using FACSDiva software (BD).
Intracellular cytokine staining. Lymphocytes were stimulated in vitro with 50 ng/ml PMA (Sigma-Aldrich) and 1 µg/ml ionomycin (SigmaAldrich) in the presence of 1 µl/ml brefeldin A (eBioscience) for 6 h before staining. FcRs were blocked before cell surface staining with anti-CD4-PerCP-Cy5.5 (RM4-5; eBioscience). After staining, cells were washed, fixed, and then permeabilized using the Cytofix/Cytoperm Plus Fixation/Permeabilization kit (BD) according to the manufacturer's instructions. Permeabilized cells were then stained with anti-IL-17-PE-Cy7 (eBio17B7) and anti-IFN--FITC (XMG1.2; all from eBioscience).
Bcl-6 staining. For detection of Bcl-6, FcRs were blocked followed by cell surface staining with anti-CD4-PE (GK1.5), anti-PD-1 (CD279)-PE-Cy7 (J43), and anti-ICOS (CD278)-FITC (C398.4A; all from eBioscience) and anti CXCR5-PE (2G8; BD). Bcl-6 staining was subsequently performed using the Foxp3/Transcription Factor Staining Buffer set (eBioscience) and anti-Bcl-6-PE (mGI191E; eBioscience).
Histology and immunohistochemistry.
Brains, spinal cords, and optic nerves were removed and fixed in 10% neutral-buffered formalin, paraffinembedded, and sectioned. Representative sections were stained with Luxol fast blue (LFB)-hematoxylin and eosin (H&E; for inflammation and demyelination) and reticulin preparation (for connective tissue) and examined by light microscopy. Meningeal and parenchymal inflammatory foci (>10 clustered inflammatory cells) were counted by a blinded observer (R.A. Sobel). Standard avidin-biotin immunohistochemical staining was performed on the sections with rabbit anti-mouse CD3 (Abcam) and rat anti-mouse CD45R (B220; BD), using reagents from Vector Laboratories. Normal mouse spleen tissue served as positive staining controls; negative controls included omission of the primary antibody. Neuropathologic analysis was performed by R.A. Sobel.
Statistical analysis.
Data are presented as mean ± SEM or SD. For clinical scores, significance between groups was examined using the Mann-Whitney U test. A value of P < 0.05 was considered significant. All other statistical analysis was performed using a one-way multiple-range ANOVA test for multiple comparisons. A value of P < 0.01 was considered significant.
We thank Dr. Patricia Nelson (University of California, San Francisco) for helpful discussion and Kara Pekarek for technical assistance. We thank Drs. Jeri-Anne Lyons and Anne H. Cross for providing us with the IgH B1-8-mem mice.
N. Molnarfi was supported by an advanced researcher fellowship from the Swiss National Science Foundation (SNF, PA00A-119532) and is a recipient of an advanced researcher exchange 2011 fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Foundation. U. Schulze-Topphoff is a fellow of the National Multiple Sclerosis Society (NMSS) and the Deutsche Forschungsgemeinschaft (DFG; SCHU 2587/1-1). M.S. Weber was supported by the NMSS (RG 4450A1/T). T. Prod'homme received fellowship support from the NMSS and Teva Neuroscience. M. Varrin-Doyer is a fellow of the NMSS. J. Hidalgo was supported by SAF2011-23272. Support for this work was provided to S.S. Zamvil by the National Institutes of Health (NIH; R01 AI-073737 and R01 NS-063008), the NMSS (RG 3913 and RG 4768), the Guthy Jackson Charitable Foundation, the Dana Foundation, and the Maisin Foundation and to M.J. Shlomchik by the NIH (R01 AI-043603).
The authors declare no competing financial interests.
Hybridoma cells were cultured in a BD Cell mAb Medium Serum-Free (BD) in large-scale flasks (Corning). mAbs were purified from hybridoma culture supernatants by the UCSF hybridoma core. (Fig. 4 D) . Serum MOGspecific IgM antibodies were measured using a noncommercial ELISA. 96-Maxisorb plates (Costar) were precoated with rmMOG (1-117) protein (10 µg/ml in PBS), blocked with BSA (Sigma-Aldrich), and incubated with sera for 2 h at the indicated dilution. After washing, MOG-specific IgM retained by the plate-bound MOG was detected with horseradish-peroxidaseconjugated anti-mouse IgM (IMMUNO-TEK). Total IgM and IgG were measured using quantitative Ig ELISA kits (IMMUNO-TEK). Total serum IgG or IgM was captured by anti-mouse IgG or IgM antibodies immobilized on micro wells. OVA-coated plates were used as negative controls for nonspecific binding. SOFTmax ELISA plate reader (450-nm wavelength) and software (Molecular Devices) were used for data analysis.
Proliferation assays. Cells were grown in RPMI supplemented with 10% FCS, -mercaptoethanol, l-glutamine, and penicillin/streptomycin. For thymidine incorporation, either 2.5 × 10 5 cells/ml of total splenocytes or 10 4 cells/ml of purified CD4 + T cells plus 2.5 × 10 5 cells/ml of purified B220 + B cells were cultured in 96-well plates in the presence of different concentrations of the rMOG proteins or MOG p35-55 (range 1-50 µg/ml). After 72 h, cells were pulsed with [ 3 H]thymidine and harvested 16 h later. Thymidine incorporation is expressed as cpm. In certain experiments, T cell proliferation was assessed by CFSE dilution assay after gating on CD4 + T cells.
Cell isolation. Single-cell leukocyte suspensions from spleens and peripheral lymph nodes (paired axillary and inguinal) were generated by gentle dissection. CNS mononuclear cells were isolated from EAE mice at peak of disease after cardiac perfusion with PBS, as described previously (Zeine and Owens, 1992) . In brief, minced CNS (spinal cord) tissues were digested with 2.5 mg/ml collagenase D (Roche) at 37°C for 45 min. Mononuclear cells were isolated by passing the tissue through 70-mm cell strainers (BD), followed by discontinuous Percoll gradient (70/30%; Sigma-Aldrich) centrifugation. Lymphocytes were collected from the 30:70% interface and washed. Total cell numbers were determined by counting on a hemocytometer, and viability was assessed by trypan blue exclusion. MACS (Miltenyi Biotec) was used to purify lymphocyte populations according to the manufacturer's instructions. CD4 + T cells were isolated by depletion of non-CD4 + T cells (negative selection, kit #130-090-860). Naive B cells were isolated by depletion from CD43-expressing B cells (activated B cells, plasma cells and CD5 + B-1a cells) and non-B cells (kit #130-090-862) according to the manufacturer's instructions. When necessary, cells were enriched a second time using a fresh MACS column to obtain >95% cell purities, as assessed by flow cytometry.
Flow cytometric analysis.
For two-to six-color immunofluorescence analysis, single-cell suspensions (10 6 cells) were incubated with anti-mouse
